Doctor after doctor misdiagnosed or shrugged off Ruth Wilson’s rashes, swelling, fevers and severe pain for six years. She ...

Coffee is the fuel of many people's morning commutes, workouts, and late-night work sessions, but a new study suggests that ...

Optain, a startup that built AI-powered retinal screening technology, acquired EyePACS to add its teleophthalmology network and expand access to eye-disease screening in primary care.

Urban smog poses a significant, often overlooked threat to eye health, leading to chronic dry eye, irritation, and ...

Outcome of Regenerative Medicine Advanced Therapy (RMAT) meeting provides the potential for an accelerated regulatory pathway to approval of OPGx-LCA5First participant enrolled in run-in period for ...

Researchers in Australia are developing an artificial intelligence (AI) tool that analyzes retinal images to detect chronic Kenya breaking news | Kenya news today | ...

Dr. Minhaj Alam is training the next generation of researchers at UNC Charlotte by teaching engineering students to use AI to ...

D Molecular Therapeutics (FDMT) announced on Thursday that its experimental drug 4D-150 demonstrated consistent and durable ...

Eyepoint Pharma ( ($EYPT) ) has released its Q3 earnings. Here is a breakdown of the information Eyepoint Pharma presented to its investors.

Viridian Therapeutics, Inc. nears profitability and gears up for veligrotug’s 2025 launch. Click here to find out why VRDN ...

No need to tell you, November got off to a great start with the rainfall. Looking at Vancouver’s rain gauge, we have had three times what would be expected so far this month. And more on the way. The ...

Vgenomics offers RgenX, an AI-powered cloud platform that diagnoses rare genetic diseases and accelerates drug discovery by ...